A ctDNA-guided approach can help identify when patients with HR-positive advanced breast cancer are developing an ESR1 ...

Biocartis’ Idylla EGFR Mutation Test has secured the EU Technical Documentation Assessment and Quality Management System ...

Multivariate analysis confirmed that patients who had a mutation with a variant allele frequency of at least 0.5% detected at day 30 had a higher risk of progression (hazard ratio, 4.48 ...

Driver mutations are the pathophysiological hallmark ... The Cox proportional-hazards model was used to estimate hazard ratios with corresponding 95% confidence intervals in a multivariable ...

In multivariate analysis, KRAS mutation correlated with shorter disease-free survival (DFS) and overall survival (OS) (hazard ratios, 1.55 and 1.56, respectively), while MSI and BRAF V600E were ...